KPV - 500 mcg/60 caps
KPV is a C-terminal peptide fragment of α-MSH intended to support a healthy immune balance and mast cell system.
- The description claims that KPV reduces intestinal inflammation through PepT1-mediated uptake.
- The description claims a critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of KPV.
- The description claims that orally targeted delivery of KPV alleviates ulcerative colitis.
Variants (1)
- Default Title — 150.00 USD — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
84%